Homozygous TNNI3 frameshift variant in a consanguineous family with lethal infantile dilated cardiomyopathy.
Pathogenic TNNI3 variant
exome sequencing
lethal neonatal DCM
Journal
Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
revised:
04
06
2024
received:
22
04
2024
accepted:
11
06
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
ppublish
Résumé
Dilated cardiomyopathy (DCM) is characterized by dilatation of the left ventricle, systolic dysfunction, and normal or reduced thickness of the left ventricular wall. It is a leading cause of heart failure and cardiac death at a young age. Cases with neonatal onset DCM were correlated with severe clinical presentation and poor prognosis. A monogenic molecular etiology accounts for nearly half of cases. Here, we report a family with three deceased offspring at the age of 1 year old. The autopsy of the first deceased infant revealed a DCM. The second infant presented a DCM phenotype with a severely reduced Left Ventricular Ejection Fraction (LVEF) of 10%. Similarly, the third infant showed a severe DCM phenotype with LVEF of 30% as well, in addition to eccentric mitral insufficiency. Exome sequencing was performed for the trio (the second deceased infant and her parents). Data analysis following the autosomal dominant and recessive patterns of inheritance was carried out along with a mitochondrial pathways-based analysis. We identified a homozygous frameshift variant in the TNNI3 gene (c.204delG; p.(Arg69AlafsTer8)). This variant has been recently reported in the ClinVar database in association with cardiac phenotypes as pathogenic or likely pathogenic and classified as pathogenic according to ACMG. Genetic counseling was provided for the family and a prenatal diagnosis of choronic villus was proposed in the absence of pre-implantation genetic diagnosis possibilities. Our study expands the case series of early-onset DCM patients with a protein-truncating variant in the TNNI3 gene by reporting three affected infant siblings.
Sections du résumé
BACKGROUND
BACKGROUND
Dilated cardiomyopathy (DCM) is characterized by dilatation of the left ventricle, systolic dysfunction, and normal or reduced thickness of the left ventricular wall. It is a leading cause of heart failure and cardiac death at a young age. Cases with neonatal onset DCM were correlated with severe clinical presentation and poor prognosis. A monogenic molecular etiology accounts for nearly half of cases.
FAMILY DESCRIPTION
UNASSIGNED
Here, we report a family with three deceased offspring at the age of 1 year old. The autopsy of the first deceased infant revealed a DCM. The second infant presented a DCM phenotype with a severely reduced Left Ventricular Ejection Fraction (LVEF) of 10%. Similarly, the third infant showed a severe DCM phenotype with LVEF of 30% as well, in addition to eccentric mitral insufficiency.
RESULTS
RESULTS
Exome sequencing was performed for the trio (the second deceased infant and her parents). Data analysis following the autosomal dominant and recessive patterns of inheritance was carried out along with a mitochondrial pathways-based analysis. We identified a homozygous frameshift variant in the TNNI3 gene (c.204delG; p.(Arg69AlafsTer8)). This variant has been recently reported in the ClinVar database in association with cardiac phenotypes as pathogenic or likely pathogenic and classified as pathogenic according to ACMG.
CONCLUSION
CONCLUSIONS
Genetic counseling was provided for the family and a prenatal diagnosis of choronic villus was proposed in the absence of pre-implantation genetic diagnosis possibilities. Our study expands the case series of early-onset DCM patients with a protein-truncating variant in the TNNI3 gene by reporting three affected infant siblings.
Substances chimiques
TNNI3 protein, human
0
Troponin I
0
Types de publication
Journal Article
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2486Subventions
Organisme : Fondation Lefoulon Delalande
Informations de copyright
© 2024 The Author(s). Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Références
Ahrens‐Nicklas, R. C., Pappas, C. T., Farman, G. P., Mayfield, R. M., Larrinaga, T. M., Medne, L., Ritter, A., Krantz, I. D., Murali, C., Lin, K. Y., Berger, J. H., Yum, S. W., Carreon, C. K., & Gregorio, C. C. (2019). Disruption of cardiac thin filament assembly arising from a mutation in LMOD2: A novel mechanism of neonatal dilated cardiomyopathy. Science Advances, 5(9), eaax2066.
Al‐Hassnan, Z. N., Almesned, A., Tulbah, S., Alakhfash, A., Alhadeq, F., Alruwaili, N., Alkorashy, M., Alhashem, A., Alrashdan, A., Faqeih, E., Alkhalifi, S. M., Al Humaidi, Z., Sogaty, S., Azhari, N., Bakhaider, A. M., Al Asmari, A., Awaji, A., Albash, B., Alhabdan, M., … Alwadai, A. (2020). Categorized genetic analysis in childhood‐onset cardiomyopathy. Circulation: Genomic and Precision Medicine, 13(5), 504–514.
Aspit, L., Levitas, A., Etzion, S., Krymko, H., Slanovic, L., Zarivach, R., Etzion, Y., & Parvari, R. (2019). CAP2 Mutation leads to impaired Actin dynamics and associates with supraventricular tachycardia and dilated cardiomyopathy. Journal of Medical Genetics, 56(4), 228–235.
Carballo, S., Robinson, P., Otway, R., Fatkin, D., Jongbloed, J. D. H., de Jonge, N., Blair, E., van Tintelen, J. P., Redwood, C., & Watkins, H. (2009). Identification and functional characterization of cardiac troponin I as a novel disease gene in autosomal dominant dilated cardiomyopathy. Circulation Research, 105(4), 375–382.
Daubeney, P. E. F., Nugent, A. W., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C. W., Weintraub, R. G., & National Australian Childhood Cardiomyopathy Study. (2006). Clinical features and outcomes of childhood dilated cardiomyopathy: Results from a national population‐based study. Circulation, 114(24), 2671–2678.
Faggiano, A., Avallone, C., Gentile, D., Provenzale, G., Toriello, F., Merlo, M., Sinagra, G., & Carugo, S. (2021). Echocardiographic advances in dilated cardiomyopathy. Journal of Clinical Medicine, 10(23), 5518.
Farah, C. S., & Reinach, F. C. (1995). The troponin complex and regulation of muscle contraction. The FASEB Journal, 9(9), 755–767.
Ganapathi, M., Argyriou, L., Martínez‐Azorín, F., Morlot, S., Yigit, G., Lee, T. M., Auber, B., von Gise, A., Petrey, D. S., Thiele, H., Cyganek, L., Sabater‐Molina, M., Ahimaz, P., Cabezas‐Herrera, J., Sorlí‐García, M., Zibat, A., Siegelin, M. D., Burfeind, P., Buchovecky, C. M., … Wollnik, B. (2020). Bi‐allelic missense disease‐causing variants in RPL3L associate neonatal dilated cardiomyopathy with muscle‐specific ribosome biogenesis. Human Genetics, 139(11), 1443–1454.
Greenway, S. C., Fruitman, D., Ferrier, R., Huculak, C., Marcadier, J., Sergi, C., & Bernier, F. P. (2021). Early death of 2 siblings related to mutations in LMOD2, a recently discovered cause of neonatal dilated cardiomyopathy. CJC Open, 3(10), 1300–1302.
Gurunathan, S., Sebastian, J., Baker, J., Abdel‐Hamid, H. Z., West, S. C., Feingold, B., Peche, V., Reyes‐Múgica, M., Madan‐Khetarpal, S., & Field, J. (2022). A homozygous CAP2 pathogenic variant in a neonate presenting with rapidly progressive cardiomyopathy and nemaline rods. American Journal of Medical Genetics Part A, 188(3), 970–977.
Hakui, H., Kioka, H., Miyashita, Y., Nishimura, S., Matsuoka, K., Kato, H., Tsukamoto, O., Kuramoto, Y., Takuwa, A., Takahashi, Y., Saito, S., Ohta, K., Asanuma, H., Fu, H. Y., Shinomiya, H., Yamada, N., Ohtani, T., Sawa, Y., Kitakaze, M., … Asano, Y. (2022). Loss‐of‐function mutations in the co‐chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation. Science Translational Medicine, 14(628), eabf3274.
Herman, D. S., Lam, L., Taylor, M. R. G., Wang, L., Teekakirikul, P., Christodoulou, D., Conner, L., DePalma, S. R., McDonough, B., Sparks, E., Teodorescu, D. L., Cirino, A. L., Banner, N. R., Pennell, D. J., Graw, S., Merlo, M., Di Lenarda, A., Sinagra, G., Bos, J. M., … Seidman, C. E. (2012). Truncations of titin causing dilated cardiomyopathy. New England Journal of Medicine, 366(7), 619–628.
Hershberger, R. E., & Jordan, E. (1993). Dilated cardiomyopathy overview. In M. P. Adam, J. Feldman, G. M. Mirzaa, R. A. Pagon, S. E. Wallace, L. J. Bean, K. W. Gripp, & A. Amemiya (Eds.), GeneReviews®. University of Washington. http://www.ncbi.nlm.nih.gov/books/NBK1309/
Iuso, A., Wiersma, M., Schüller, H. J., Pode‐Shakked, B., Marek‐Yagel, D., Grigat, M., Schwarzmayr, T., Berutti, R., Alhaddad, B., Kanon, B., Grzeschik, N. A., Okun, J. G., Perles, Z., Salem, Y., Barel, O., Vardi, A., Rubinshtein, M., Tirosh, T., Dubnov‐Raz, G., … Anikster, Y. (2018). Mutations in PPCS, encoding Phosphopantothenoylcysteine Synthetase, cause autosomal‐recessive dilated cardiomyopathy. American Journal of Human Genetics, 102(6), 1018–1030.
Jammal Addin, M. B., Young, D., McCarrison, S., & Hunter, L. (2019). Dilated cardiomyopathy in a national paediatric population. European Journal of Pediatrics, 178(8), 1229–1235.
Janin, A., Perouse de Montclos, T., Nguyen, K., Consolino, E., Nadeau, G., Rey, G., Bouchot, O., Blanchet, P., Sabbagh, Q., Cazeneuve, C., el‐Malti, R., Morel, E., Delinière, A., Chevalier, P., & Millat, G. (2022). Molecular diagnosis of primary cardiomyopathy in 231 unrelated pediatric cases by panel‐based next‐generation sequencing: A major focus on five carriers of Biallelic TNNI3 pathogenic variants. Molecular Diagnosis & Therapy, 26(5), 551–560.
Jones, E. G., Mazaheri, N., Maroofian, R., Zamani, M., Seifi, T., Sedaghat, A., Shariati, G., Jamshidi, Y., Allen, H. D., Wehrens, X. H. T., Galehdari, H., & Landstrom, A. P. (2019). Analysis of enriched rare variants in JPH2‐encoded junctophilin‐2 among greater middle eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy. Scientific Reports, 9(1), 9038.
Jordan, E., Peterson, L., Ai, T., Asatryan, B., Bronicki, L., Brown, E., Celeghin, R., Edwards, M., Fan, J., Ingles, J., James, C. A., Jarinova, O., Johnson, R., Judge, D. P., Lahrouchi, N., Lekanne Deprez, R. H., Lumbers, R. T., Mazzarotto, F., Medeiros Domingo, A., … Hershberger, R. E. (2021). Evidence‐based assessment of genes in dilated cardiomyopathy. Circulation, 144(1), 7–19.
Kühnisch, J., Herbst, C., Al‐Wakeel‐Marquard, N., Dartsch, J., Holtgrewe, M., Baban, A., Mearini, G., Hardt, J., Kolokotronis, K., Gerull, B., Carrier, L., Beule, D., Schubert, S., Messroghli, D., Degener, F., Berger, F., & Klaassen, S. (2019). Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3. Clinical Genetics, 96(6), 549–559.
Mahmaljy, H., Yelamanchili, V. S., & Singhal, M. (2024). Dilated cardiomyopathy. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK441911/
McNally, E. M., & Mestroni, L. (2017). Dilated cardiomyopathy. Circulation Research, 121(7), 731–748.
Mestroni, L., Brun, F., Spezzacatene, A., Sinagra, G., & Taylor, M. R. (2014). Genetic causes of dilated cardiomyopathy. Progress in Pediatric Cardiology, 37(1–2), 13–18.
Mestroni, L., Rocco, C., Gregori, D., Sinagra, G., Di Lenarda, A., Miocic, S., Vatta, M., Pinamonti, B., Muntoni, F., Caforio, A. L., McKenna, W. J., Falaschi, A., Giacca, M., & Camerini. (1999). Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. Journal of the American College of Cardiology, 34(1), 181–190.
Murphy, R. T., Mogensen, J., Shaw, A., Kubo, T., Hughes, S., & McKenna, W. J. (2004). Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. The Lancet, 363(9406), 371–372.
Pezzoli, L., Pezzani, L., Bonanomi, E., Marrone, C., Scatigno, A., Cereda, A., Bedeschi, M. F., Selicorni, A., Gasperini, S., Bini, P., Maitz, S., Maccioni, C., Pedron, C., Colombo, L., Marchetti, D., Bellini, M., Lincesso, A. R., Perego, L., Pingue, M., … Iascone, M. (2021). Not only diagnostic yield: Whole‐exome sequencing in infantile cardiomyopathies impacts on clinical and family management. Journal of Cardiovascular Development and Disease, 9(1), 2.
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier‐Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405–424.
Ruijmbeek, C. W., Housley, F., Idrees, H., Housley, M. P., Pestel, J., Keller, L., Lai, J. K., der Linde, H. C. V., Willemsen, R., Piesker, J., Al‐Hassnan, Z. N., Almesned, A., Dalinghaus, M., den Bersselaar, L. M. V., van Slegtenhorst, M. A., Tessadori, F., Bakkers, J., van Ham, T. J., Stainier, D. Y., … Reischauer, S. (2023). Biallelic variants in FLII cause pediatric cardiomyopathy by disrupting cardiomyocyte cell adhesion and myofibril organization. JCI Insight, 8(17), e168247.
Seidel, F., Holtgrewe, M., Al‐Wakeel‐Marquard, N., Opgen‐Rhein, B., Dartsch, J., Herbst, C., Beule, D., Pickardt, T., Klingel, K., Messroghli, D., Berger, F., Schubert, S., Kühnisch, J., & Klaassen, S. (2021). Pathogenic variants associated with dilated cardiomyopathy predict outcome in pediatric myocarditis. Circulation: Genomic and Precision Medicine, 14(4), e003250.
Soares, P., Rocha, G., Pissarra, S., Soares, H., Flôr‐de‐Lima, F., Costa, S., Moura, C., Dória, S., & Guimarães, H. (2017). Neonatal dilated cardiomyopathy. Revista Portuguesa de Cardiologia, 36(3), 201–214.
Sorrentino, U., Gabbiato, I., Canciani, C., Calosci, D., Rigon, C., Zuccarello, D., & Cassina, M. (2023). Homozygous TNNI3 mutations and severe early onset dilated cardiomyopathy. Patient Report and Review of the Literature Genes, 14(3), 748.
Sweet, M., Taylor, M. R. G., & Mestroni, L. (2015). Diagnosis, prevalence, and screening of familial dilated cardiomyopathy. Expert Opinion on Orphan Drugs, 3(8), 869–876.
Theis, J. L., Bos, J. M., Bartleson, V. B., Will, M. L., Binder, J., Vatta, M., Towbin, J. A., Gersh, B. J., Ommen, S. R., & Ackerman, M. J. (2006). Echocardiographic‐determined septal morphology in Z‐disc hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 351(4), 896–902.
van den Wijngaard, A., Volders, P., Van Tintelen, J. P., Jongbloed, J. D. H., van den Berg, M. P., Lekanne Deprez, R. H., Mannens, M. M., Hofmann, N., Slegtenhorst, M., Dooijes, D., Michels, M., Arens, Y., Jongbloed, R., & Smeets, B. J. (2011). Recurrent and founder mutations in The Netherlands: Cardiac troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy. Netherlands Heart Journal, 19(7–8), 344–351.
Vasilescu, C., Ojala, T. H., Brilhante, V., Ojanen, S., Hinterding, H. M., Palin, E., Alastalo, T. P., Koskenvuo, J., Hiippala, A., Jokinen, E., Jahnukainen, T., Lohi, J., Pihkala, J., Tyni, T. A., Carroll, C. J., & Suomalainen, A. (2018). Genetic basis of severe childhood‐onset cardiomyopathies. Journal of the American College of Cardiology, 72(19), 2324–2338.
Verhagen, J. M., van den Born, M., van der Linde, H. C., Nikkels, P. G. J., Verdijk, R. M., Kivlen, M. H., van Unen, L. M., Baas, A. F., Ter Heide, H., van Osch‐Gevers, L., & Hoogeveen‐Westerveld, M. (2019). Biallelic variants in ASNA1, encoding a cytosolic targeting factor of tail‐anchored proteins, cause rapidly progressive pediatric cardiomyopathy. Circulation: Genomic and Precision Medicine, 12(9), 397–406.
Yuen, M., Worgan, L., Iwanski, J., Pappas, C. T., Joshi, H., Churko, J. M., Arbuckle, S., Kirk, E. P., Zhu, Y., Roscioli, T., Gregorio, C. C., & Cooper, S. T. (2022). Neonatal‐lethal dilated cardiomyopathy due to a homozygous LMOD2 donor splice‐site variant. European Journal of Human Genetics, 30(4), 450–457.